Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Marian

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Current Cancer Drug Targets|June 11, 2009
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapyK V Gleixner, M Mayerhofer, A Vales, et al.
British Journal of Cancer|June 2, 2011
NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cellsC Vonach, K Viola, B Giessrigl, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Current Cancer Drug Targets|June 11, 2009
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapyK V Gleixner, M Mayerhofer, A Vales, et al.
British Journal of Cancer|June 2, 2011
NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cellsC Vonach, K Viola, B Giessrigl, et al.
Pageof 5